Cargando…

Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!

INTRODUCTION: Management of renal calculus in a patient of chronic kidney disease (CKD) is always challenging. Treatment options include extracorporeal shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy (PCNL). With PCNL being gold standard for renal calculus ≥1....

Descripción completa

Detalles Bibliográficos
Autores principales: Adiga, Pramod, Pudakalkatti, Sanjay Ramachandra, Shivakumar, V., Jain, Mayank, Sreenidhi, R. Navaneeth, Manohar, C. S., Jayaram, Sreenivas, Nagabhushan, M., Keshavamurthy, Ramaiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731184/
https://www.ncbi.nlm.nih.gov/pubmed/36506001
http://dx.doi.org/10.4103/ua.ua_100_21
_version_ 1784845853106634752
author Adiga, Pramod
Pudakalkatti, Sanjay Ramachandra
Shivakumar, V.
Jain, Mayank
Sreenidhi, R. Navaneeth
Manohar, C. S.
Jayaram, Sreenivas
Nagabhushan, M.
Keshavamurthy, Ramaiah
author_facet Adiga, Pramod
Pudakalkatti, Sanjay Ramachandra
Shivakumar, V.
Jain, Mayank
Sreenidhi, R. Navaneeth
Manohar, C. S.
Jayaram, Sreenivas
Nagabhushan, M.
Keshavamurthy, Ramaiah
author_sort Adiga, Pramod
collection PubMed
description INTRODUCTION: Management of renal calculus in a patient of chronic kidney disease (CKD) is always challenging. Treatment options include extracorporeal shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy (PCNL). With PCNL being gold standard for renal calculus ≥1.5 cm in normal kidneys, we aimed to analyze the safety and efficacy of PCNL in CKD patients with calculus ≥1.5 cm. MATERIALS AND METHODS: Sixty patients of CKD with renal calculus were included in the study: Group A with glomerular filtration rate (GFR) ≤30 ml/min/m(2) and Group B with GFR >30 <60 ml/min/m(2). The estimated GFR (eGFR) pre-PCNL, peak eGFR on follow-up, and eGFR at last follow-up, stone free rates, and complications were recorded. The CKD stage before and after PCNL were also compared at the last follow-up. RESULTS: The mean age of patients was 52 years. A mean of 1.14sittings per renal unit was required for PCNL. Complete clearance was 94% after all auxiliary procedures. The mean prePCNL eGFR was 26.5 ± 4.01 and 43.6 ± 9l. 14 ml/min/1.73 m(2) in Groups A and B, respectively. The mean post-PCNL eGFR was 32 ± 9.94 and 51 ± 8.85 ml/minute/1.73 m2, respectively, in Groups A and B. At a mean follow-up of 180 days, deterioration with the migration of CKD stage was seen in 13 patients (21.6%) out of which 10 patients were of Groups A and 3 in Group B. Six patients (10%) required maintenance hemodialysis. Postoperative bleeding complication requiring blood transfusions was seen in 12 (20%) and 3 (5%) required intensive care unit care postoperatively. No mortality was observed in our study. CONCLUSION: PCNL is an effective management strategy for renal calculus in patients with CKD with an acceptable stone clearance rates and manageable complications. Peak eGFR <30 ml/min/m2 and postprocedure complications predict deterioration and need for RRT.
format Online
Article
Text
id pubmed-9731184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-97311842022-12-09 Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!! Adiga, Pramod Pudakalkatti, Sanjay Ramachandra Shivakumar, V. Jain, Mayank Sreenidhi, R. Navaneeth Manohar, C. S. Jayaram, Sreenivas Nagabhushan, M. Keshavamurthy, Ramaiah Urol Ann Original Article INTRODUCTION: Management of renal calculus in a patient of chronic kidney disease (CKD) is always challenging. Treatment options include extracorporeal shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy (PCNL). With PCNL being gold standard for renal calculus ≥1.5 cm in normal kidneys, we aimed to analyze the safety and efficacy of PCNL in CKD patients with calculus ≥1.5 cm. MATERIALS AND METHODS: Sixty patients of CKD with renal calculus were included in the study: Group A with glomerular filtration rate (GFR) ≤30 ml/min/m(2) and Group B with GFR >30 <60 ml/min/m(2). The estimated GFR (eGFR) pre-PCNL, peak eGFR on follow-up, and eGFR at last follow-up, stone free rates, and complications were recorded. The CKD stage before and after PCNL were also compared at the last follow-up. RESULTS: The mean age of patients was 52 years. A mean of 1.14sittings per renal unit was required for PCNL. Complete clearance was 94% after all auxiliary procedures. The mean prePCNL eGFR was 26.5 ± 4.01 and 43.6 ± 9l. 14 ml/min/1.73 m(2) in Groups A and B, respectively. The mean post-PCNL eGFR was 32 ± 9.94 and 51 ± 8.85 ml/minute/1.73 m2, respectively, in Groups A and B. At a mean follow-up of 180 days, deterioration with the migration of CKD stage was seen in 13 patients (21.6%) out of which 10 patients were of Groups A and 3 in Group B. Six patients (10%) required maintenance hemodialysis. Postoperative bleeding complication requiring blood transfusions was seen in 12 (20%) and 3 (5%) required intensive care unit care postoperatively. No mortality was observed in our study. CONCLUSION: PCNL is an effective management strategy for renal calculus in patients with CKD with an acceptable stone clearance rates and manageable complications. Peak eGFR <30 ml/min/m2 and postprocedure complications predict deterioration and need for RRT. Wolters Kluwer - Medknow 2022 2022-06-03 /pmc/articles/PMC9731184/ /pubmed/36506001 http://dx.doi.org/10.4103/ua.ua_100_21 Text en Copyright: © 2022 Urology Annals https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Adiga, Pramod
Pudakalkatti, Sanjay Ramachandra
Shivakumar, V.
Jain, Mayank
Sreenidhi, R. Navaneeth
Manohar, C. S.
Jayaram, Sreenivas
Nagabhushan, M.
Keshavamurthy, Ramaiah
Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title_full Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title_fullStr Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title_full_unstemmed Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title_short Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
title_sort is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731184/
https://www.ncbi.nlm.nih.gov/pubmed/36506001
http://dx.doi.org/10.4103/ua.ua_100_21
work_keys_str_mv AT adigapramod ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT pudakalkattisanjayramachandra ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT shivakumarv ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT jainmayank ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT sreenidhirnavaneeth ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT manoharcs ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT jayaramsreenivas ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT nagabhushanm ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients
AT keshavamurthyramaiah ispercutaneousnephrolithotomysafeinchronickidneydiseasepatients